Cybin Inc


Trade Assets

timeline: 12 months

A leader in the emerging field of psychedelic science, Cybin is a biotechnology company focused on the creation of novel compounds using classic psychedelic substances such as psilocybin and DMT. Our team worked with Cybin to develop their branding and communications from the earliest stages of development through their IPO and initial rounds of acquisitions and patent filings.


visit website